Healthcare services must prepare for a world where Alzheimer’s disease is treatable

Drugs with the potential to change the course of Alzheimer’s disease are expected to be approved by mid-year in the UK, but the NHS may struggle to ensure equitable access, suggests research led by Professor Rimona Weil, (UCL Queen Square Institute of Neurology).

Read: The Telegraph (£); More: The Scottish Sun, The Sun, Daily Mail, Daily Mail (2), Birmingham Live, ScienceMag, Teknomers (France), UCL News